Pancreatic Cancer Research

ResearcherSoongsil UniversityActive in the last 2 years

Kyungdo Han

Matched on ORCID iD 0000-0002-6096-1263; OpenAlex author ID A5047846074. Sources: OpenAlex.

Their work

Papers
14 (first author 5, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 3 papers · 2024: none · 2025: 2 papers · 2026: 5 papers

Papers 14

  1. Prediabetes Remission and the Subsequent Risk of Pancreatic Cancer: A Nationwide Cohort Study. Co-author DOI 10.1016/j.amepre.2025.107979↗
  2. Increased risk of young-onset pancreatic cancer among adults aged 20-39 years with overweight or obesity, but not underweight: A nationwide cohort study. Co-author DOI 10.1016/j.ejca.2025.116111↗
  3. Parity and Risk of Pancreatic Cancer Among Premenopausal Women: A Nationwide Cohort Study. Co-author DOI 10.1016/j.mayocp.2026.05.020↗
  4. Lower glycemic status was associated with pancreatic cancer risk in prediabetes, but not in diabetes: A nationwide cohort study. Co-author DOI 10.1111/jdi.70205↗
  5. Reply to: "Beyond Average Grams: Aldehyde Dehydrogenase 2*2 and Alcohol-Induced Young-Onset Pancreatic Cancer" and "Uncontrolled Prediabetes Confounding in the… Last author DOI 10.1200/jco-26-01147↗
  6. Risk of pancreatic cancer according to glycemic status in nonalcoholic fatty liver disease: a nationwide cohort study. Co-author DOI 10.1038/s41598-025-05868-3↗
  7. Risk of Biliary Tract and Pancreatic Cancer Following Obstructive Sleep Apnea Diagnosis: Analysis of a National Health Insurance Database. Co-author DOI 10.18787/jr.2025.00012↗
  8. Impact of cumulative hyperglycemic burden on the pancreatic cancer risk: A nationwide cohort study. First author DOI 10.1016/j.diabres.2022.110208↗
  9. Risk of Pancreatic Cancer and Use of Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes: A Propensity Score-Matching Analysis. First author DOI 10.3803/enm.2023.1737↗
  10. Smoking Cessation and Pancreatic Cancer Risk in Individuals With Prediabetes and Diabetes: A Nationwide Cohort Study. Co-author DOI 10.6004/jnccn.2023.7060↗
  11. Association between alcohol consumption and pancreatic cancer risk differs by glycaemic status: A nationwide cohort study. First author DOI 10.1016/j.ejca.2021.12.027↗
  12. Increased risk of pancreatic cancer in individuals with non-alcoholic fatty liver disease. Co-author DOI 10.1038/s41598-022-14856-w↗
  13. Middle-aged men with type 2 diabetes as potential candidates for pancreatic cancer screening: a 10-year nationwide population-based cohort study. First author DOI 10.1007/s00592-019-01405-7↗
  14. The Incremental Risk of Pancreatic Cancer According to Fasting Glucose Levels: Nationwide Population-Based Cohort Study. First author DOI 10.1210/jc.2019-00033↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jung Yong Hong · 7 shared papers, 2022–2026 · strength 2.13
  2. Joo‐Hyun Park · 6 shared papers, 2022–2026 · strength 1.77
  3. Young Suk Park · 4 shared papers, 2022–2026 · strength 1.09
  4. Dong‐Hoe Koo · 4 shared papers, 2019–2026 · strength 1.06
  5. Cheol‐Young Park · 4 shared papers, 2019–2026 · strength 1.06
  6. Joon Oh Park · 3 shared papers, 2022–2026 · strength 0.74
  7. Ho Yeong Lim · 2 shared papers, 2026 · strength 0.65
  8. Ho Yeong Lim · 1 shared paper, 2026 · strength 0.36
  9. J Y Park · 1 shared paper, 2026 · strength 0.36
  10. Hyun‐Jin Kim · 1 shared paper, 2026 · strength 0.33
  11. Ji Ho Choi · 1 shared paper, 2025 · strength 0.30
  12. Marn Joon Park · 1 shared paper, 2025 · strength 0.30
  13. Soon Jib Yoo · 1 shared paper, 2023 · strength 0.26
  14. Mee Kyoung Kim · 1 shared paper, 2023 · strength 0.26
  15. Boram Han · 1 shared paper, 2025 · strength 0.23
  16. Han Na Jung · 1 shared paper, 2025 · strength 0.23
  17. Sung‐Hee Ihm · 1 shared paper, 2025 · strength 0.23
  18. Joo Kyung Park · 1 shared paper, 2022 · strength 0.20
  19. Hong Joo Kim · 1 shared paper, 2020 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.